Less toxic bone marrow transplants on horizon

August 10, 2016

Bone marrow transplants that do not require dangerous and often toxic chemotherapy could soon be possible, US researchers said Wednesday after seeing initial success with experiments on mice.

The method developed by a team of scientists at Stanford University mimics the approach used in immunotherapy, in which cancer patients undergo a treatment that trains their immune systems to attack .

If it works in humans, it could help improve treatments for lupus, juvenile diabetes, multiple sclerosis, organ transplants and even cancer.

"There is almost no category of disease or that is not impacted by this research," said Irving Weissman, professor of pathology and of developmental biology at Stanford and co-author of the report in the August 10 edition of the journal Science Translational Medicine.

Currently, anyone receiving a bone marrow transplant—also known as a stem cell transplant—must undergo chemotherapy or radiotherapy to kill the patient's own population of first.

That makes the potentially life-saving operation dangerous and even fatal for up to one in five patients. Organ, nerve and brain damage can also result.

So researchers devised a new approach that includes an antibody and biologic agents that helped the mice's own immune systems deplete their blood-forming stem cells, making way for from a donor.

"If it works in humans like it did in mice, we would expect that the risk of death from blood stem cell transplant would drop from 20 percent to effectively zero," said the paper's senior author, Judith Shizuru, a professor of medicine at Stanford.

More research is planned for studies involving people.

Explore further: New approach could make bone marrow transplants safer

Related Stories

New approach could make bone marrow transplants safer

June 6, 2016
Harvard Stem Cell Institute (HSCI) scientists have taken the first steps toward developing a treatment that would make bone marrow - blood stem cell - transplantation safer and, as a result, more widely available to the millions ...

Cord blood outperforms matched, unrelated donor in bone marrow transplant

July 26, 2016
A University of Colorado Cancer Center study compared outcomes of leukemia patients receiving bone marrow transplants from 2009-2014, finding that three years post transplant, the incidence of severe chronic graft-versus-host ...

Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma

June 6, 2016
Children with high-risk neuroblastoma whose treatment included two autologous stem-cell transplants were more likely to be free of cancer three years later than patients who underwent a single transplant, a Phase 3 clinical ...

Immunotherapy benefits relapsed stem cell transplant recipients

July 13, 2016
For many patients with advanced blood cancers, a stem-cell transplant can drive the disease into remission. However, about one-third of these patients experience a relapse and face a very poor prognosis.

No survival advantage with peripheral blood stem cells versus bone marrow

October 19, 2012
(Medical Xpress)—Claudio Anasetti, M.D., chair of the Department of Blood & Marrow Transplant at Moffitt Cancer Center, and colleagues from 47 research sites in the Blood and Marrow Transplant Clinical Trials Network conducted ...

Recommended for you

Link between cells associated with aging and bone loss

August 21, 2017
Mayo Clinic researchers have reported a causal link between senescent cells - the cells associated with aging and age-related disease - and bone loss in mice. Targeting these cells led to an increase in bone mass and strength. ...

Are stem cells the link between bacteria and cancer?

August 17, 2017
Gastric carcinoma is one of the most common causes of cancer-related deaths, primarily because most patients present at an advanced stage of the disease. The main cause of this cancer is the bacterium Helicobacter pylori, ...

Two-step process leads to cell immortalization and cancer

August 17, 2017
A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally ...

New Pathology Atlas maps genes in cancer to accelerate progress in personalized medicine

August 17, 2017
A new Pathology Atlas is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns ...

Female mouse embryos actively remove male reproductive systems

August 17, 2017
A protein called COUP-TFII determines whether a mouse embryo develops a male reproductive tract, according to researchers at the National Institutes of Health and their colleagues at Baylor College of Medicine, Houston. The ...

New technique overcomes genetic cause of infertility

August 17, 2017
Scientists have created healthy offspring from genetically infertile male mice, offering a potential new approach to tackling a common genetic cause of human infertility.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.